🔴 Cerenome is trading 7.3% down on October 26, 2026 — no clear catalyst confirmed

Cerenome is trading 7.32% lower at $1.52, with no clear catalyst confirmed.

• No company-specific announcement dated October 26 appears in its listed press releases; the latest listed release is dated October 21.
• That release described preclinical findings for REYOBIQ, but available reporting does not establish it as the cause of the decline. Major-index context is positive, so broad-market weakness does not explain the move.